U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
2024-11-20
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings and Walmart on Wednesday.

HIGHLIGHTS

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57

* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185

* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight

* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310

* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Aerovironment Inc AVAV.O: Jefferies cuts target price to $230 from $240

* Aerovironment Inc AVAV.O: Jefferies raises to buy from hold

* Annexon Inc ANNX.O: JP Morgan cuts target price to $9 from $11

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57

* Arbutus Biopharma Corp ABUS.O: Chardan Capital Markets raises PT to $5 from $4.5

* Azek Company Inc AZEK.N: RBC raises target price to $50 from $46

* Bellring Brands Inc BRBR.N: JP Morgan raises target price to $84 from $64

* Berry Global Group Inc BERY.N: Baird raises target price to $70 from $65

* Bridgebio pharma Inc BBIO.O: JP Morgan cuts target price to $40 from $43

* Caseys General Stores Inc CASY.O: JP Morgan raises target price to $338 from $337

* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185

* Dyne Therapeutics DYN.O: JP Morgan cuts target price to $34 from $35

* Energizer Holdings Inc ENR.N: JP Morgan raises target price to $39 from $32

* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight

* Firstsun Capital Bancorp FSUN.O: Raymond James raises to outperform from market perform

* I3 Verticals Inc IIIV.O: Raymond James raises target price to $30 from $28

* Labcorp LH.N: Mizuho raises target price to $264 from $256

* Lowe's Companies Inc LOW.N: HSBC raises target price to $262 from $260

* Lowe's Companies Inc LOW.N: Jefferies raises target price to $301 from $274

* Lowe's Companies Inc LOW.N: RBC raises target price to $291 from $290

* Monopar Therapeutics Inc MNPR.O: Jonestrading raises target price to $37 from $9

* Northern Oil and Gas Inc NOG.N: RBC cuts to sector perform from outperform

* Northern Oil and Gas Inc NOG.N: RBC raises target price to $45 from $43

* Nuvalent Inc NUVL.O: JP Morgan cuts target price to $121 from $125

* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts PT to $15 from $17

* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts to neutral from overweight

* Oaktree Specialty Lending Corp OCSL.O: KBW cuts target price to $17 from $18

* Olema Pharmaceuticals Inc OLMA.O: JP Morgan cuts target price to $29 from $31

* P3 Health Partners Inc PIII.O: TD Cowen cuts target price to $0.25 from $0.90

* PBF Energy Inc PBF.N: JP Morgan cuts target price to $37 from $40

* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310

* Springworks Therapeutics Inc SWTX.O: JP Morgan raises target price to $70 from $68

* Travere Therapeutics Inc TVTX.O: JP Morgan cuts target price to $42 from $43

* Valvoline Inc VVV.N: JP Morgan cuts target price to $37 from $40

* Valvoline Inc VVV.N: RBC cuts target price to $46 from $52

* Vera Therapeutics Inc VERA.O: JP Morgan raises target price to $77 from $75

* Vir Biotechnology Inc VIR.O: JP Morgan cuts target price to $10 from $13

* Walmart WMT.N: Jefferies raises target price to $105 from $100

* Walmart WMT.N: RBC raises target price to $96 from $92

* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10